Drug Type ASO |
Synonyms |
Target |
Mechanism Bcl-2 inhibitors(Apoptosis regulator Bcl-2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Recurrent Chronic Lymphoid Leukemia | Phase 2 | FR | 01 Jun 2005 | |
Recurrent Chronic Lymphoid Leukemia | Phase 2 | DK | 01 Jun 2005 | |
Recurrent Chronic Lymphoid Leukemia | Phase 2 | US | 01 Jun 2005 | |
Recurrent Chronic Lymphoid Leukemia | Phase 2 | GB | 01 Jun 2005 | |
Chronic Lymphocytic Leukemia | Phase 2 | - | - | |
Chronic Lymphocytic Leukemia | Phase 2 | - | - | |
Non-Hodgkin Lymphoma | Phase 2 | - | - |
Phase 1/2 | 25 | cxjwkespsn(rxdhbjhdvr) = ydlaivqbdl mlodxtvfbo (cinajpgwzg ) View more | - | 20 Jun 2007 |